The synthesis of melanin pigments, or melanogenesis, is regulated by the balance of a variety of signal transduction pathways. Among these pathways, p38 MAPK signaling was found to be involved in stress-induced melanogenesis and to be activated by ␣-melanocyte-stimulating hormone (␣-MSH) and ultraviolet irradiation. Previous studies have shown that ␣-MSH-stimulated melanogenesis can be inhibited by blocking p38 MAPK activity with SB203580, a pyridinyl imidazole compound. Consistent with this, we observed that pyridinyl imidazoles (SB203580 and SB202190) inhibited both basal and ␣-MSH-induced melanogenesis in B16 melanoma cells. However, SB202474, which has no ability to inhibit p38 MAPK activity and is usually used as a negative control compound in p38 MAPK studies, also suppressed melanin synthesis induction. Furthermore, the independence of the p38 kinase pathway from the repression of melanogenesis by pyridinyl imidazole compounds was also confirmed by small interfering RNA experiments. Interfering with p38 MAPK expression surprisingly stimulated melanogenesis and tyrosinase family protein expression. Although the molecular mechanism(s) by which p38 promotes the degradation of melanogenic enzymes remain to be determined, the involvement of the ubiquitin-proteasome pathway was demonstrated by co-treatment with the proteasomespecific inhibitor MG132 and the relative decrease in the ubiquitination of tyrosinase in cells transfected with p38-specific small interfering RNA.Skin pigmentation, which results from the production and distribution of melanin in the epidermis, is the major physiological defense against solar irradiation. In mammalian melanocytes, melanins are synthesized within melanosomes that contain three major pigment enzymes: tyrosinase and tyrosinase-related protein-1 (TRP-1) 2 and dopachrome tautomerase (DCT), also known as tyrosinase related protein-2 (TRP-2) (1-5). Melanin synthesis is stimulated by a large number of effectors, including cAMP-elevating agents (forskolin, isobutylmethylxanthine, ␣-MSH) (6 -8), cholera toxin (9), UV light (10 -12), placental total lipid fraction (13), lupeol (14), lipopolysaccharide (15), GSK3 signaling pathway blocker (16), rosmarinic acid (17), the phosphatidylinositol 3-kinase inhibitor LY294002 (18), and the MEK inhibitor PD98059 (19). The balance of a variety of signal transduction pathways regulates melanogenesis. Thus far, one of the most important signaling pathways found to induce melanogenesis is the cAMP/protein kinase A (PKA) pathway. Cyclic AMP, through the activation of PKA and cAMP-responsive element binding protein 1 transcription factors, up-regulates the expression of microphthalmia-associated transcription factor (Mitf), the master regulator of melanogenesis that controls the production of the melanogenic enzymes (tyrosinase, TRP-1, and DCT) (20 -23) at the mRNA level. In addition, cAMP activates the ERK pathway, which also plays a key role in melanin synthesis (24), at least in part through the regulation of Mitf activation and stability (25,2...